Ageing and Dementia: Journal of Neural Transmission. Supplementa, cartea 53
Editat de Kurt Jellinger, Franz Fazekas, Manfred Windischen Limba Engleză Paperback – 13 iul 1998
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1377.14 lei 6-8 săpt. | |
| SPRINGER VIENNA – 13 iul 1998 | 1377.14 lei 6-8 săpt. | |
| Hardback (1) | 1483.52 lei 38-44 zile | |
| SPRINGER VIENNA – 15 iul 1998 | 1483.52 lei 38-44 zile |
Din seria Journal of Neural Transmission. Supplementa
- 5%
Preț: 1073.37 lei - 5%
Preț: 406.99 lei -
Preț: 375.07 lei - 5%
Preț: 347.95 lei - 5%
Preț: 685.11 lei - 5%
Preț: 351.75 lei -
Preț: 365.29 lei - 5%
Preț: 362.13 lei -
Preț: 366.02 lei - 15%
Preț: 640.03 lei - 5%
Preț: 1070.64 lei - 5%
Preț: 354.73 lei - 5%
Preț: 359.65 lei -
Preț: 376.37 lei - 15%
Preț: 618.50 lei -
Preț: 367.12 lei - 5%
Preț: 379.31 lei - 5%
Preț: 360.53 lei -
Preț: 382.85 lei - 5%
Preț: 364.92 lei - 5%
Preț: 350.52 lei - 5%
Preț: 358.80 lei - 5%
Preț: 358.05 lei - 5%
Preț: 372.32 lei - 5%
Preț: 1483.52 lei - 5%
Preț: 367.54 lei - 5%
Preț: 353.55 lei - 5%
Preț: 755.18 lei - 18%
Preț: 1345.81 lei - 5%
Preț: 1369.44 lei - 5%
Preț: 1373.11 lei - 5%
Preț: 1053.20 lei - 5%
Preț: 686.90 lei - 5%
Preț: 1069.88 lei - 5%
Preț: 1098.13 lei - 5%
Preț: 691.96 lei - 5%
Preț: 1410.29 lei - 5%
Preț: 2141.59 lei - 5%
Preț: 1463.76 lei
Preț: 1377.14 lei
Preț vechi: 1449.63 lei
-5%
Puncte Express: 2066
Preț estimativ în valută:
243.47€ • 290.89$ • 210.91£
243.47€ • 290.89$ • 210.91£
Carte tipărită la comandă
Livrare economică 14-28 martie
Specificații
ISBN-13: 9783211831144
ISBN-10: 3211831142
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 22 mm
Greutate: 0.99 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
ISBN-10: 3211831142
Pagini: 416
Ilustrații: VIII, 407 p.
Dimensiuni: 210 x 297 x 22 mm
Greutate: 0.99 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER VIENNA
Colecția Springer
Seria Journal of Neural Transmission. Supplementa
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies.- Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study).- Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study.- The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates.- Cognitive correlates of cerebral white matter changes.- Concepts on the prognostic significance of white matter changes.- Difficulties in the clinical diagnosis of vascular dementia and dementia of the Alzheimer type — comparison of clinical classifications.- Problems of differential diagnosis between depressive pseudo- dementia and Alzheimer’s disease.- The neuropathological diagnosis of Alzheimer disease.- The progression of the lesions in Alzheimer disease: insights from a prospective clinico- pathological study.- Evolution of neuronal changes in the course of Alzheimer’s disease.- The cytoskeleton in Alzheimer disease.- Mechanisms of synaptic pathology in Alzheimer’s disease.- Proteolytic processing of Alzheimer’s disease associated proteins.- Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.- Presenilins and Alzheimer’s disease: the role of A?42.- Biological markers for the diagnosis of Alz- heimer’s disease.- Apolipoprotein E4, cholinergic integrity and the pharmaco- genetics of Alzheimer’s disease.- Cerebrospinal fluid levels of A?42 and tau: potential markers of Alzheimer’s disease.- Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing.- Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia.- Current diagnostic methods andoutcome variables for clinical investigation of Alzheimer’s disease.- Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs.- The role of glutamate in dementia.- Neurotrophic activities and therapeutic experience with a brain-derived peptide preparation.- Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats.- The influence of Cerebrolysin® and E021 on spatial navigation of 24-month-old rats.- Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors.- Antioxidant systemic effect of short-term Cerebrolysin® administration.- Can Cerebrolysin® influence chronic deterioration of spatial learning and memory?.- Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.- Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro.- Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro.- Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.